Biological barriers are truly one of the most perfect biological machines to have been studied. They perform a primary function of preventing undesired access to sensitive organs, while allowing for limited and selected passage across. They thereby manage access of a variety of molecules and assemblies with an efficiency and fidelity that no man-made engineered filter or barrier can even approach. Without such a barrier, for example the lungs, our bloodstream and subsequently all our organs would be exposed to a multitude of dangerous inhalation scenarios. Most delicate of all, the brain would be unable to function in the face of a variety of infections and other challenges. The basis of the success of the biological barrier is that the primary component of the barrier is composed of an array of tightly joined cells backed up by an array of other cells involved in clearance, immunity and other processes. Thus, while some very small molecular weight molecules can diffuse or passively partition across the barriers, most molecules and other undesirable larger assemblies are excluded, or removed, by active biological processes. Those larger molecules that pass the barrier must traffic across using active energy dependent biological processes, during which they are exposed to many intracellular checks and analyses. Naturally, the very success of biological barriers in excluding passage can present very significant (arguably, currently often insuperable) challenges for the delivery of therapies across the barriers. For example, many of the more intractable human brain-related diseases ranging from neurodegeneration, persistent drug cocktail resistant viral infection (HIV for example), and glioblastomas, are exacerbated by the difficulty of gaining therapeutic access to the brain. Great inconvenience and expense is added to numerous other therapeutic scenarios in which biological barriers have to be crossed before drugs can act. Nanomedicine, were it to allow us to address these challenges, would by this achievement alone change the face of medicine, and justify the endeavour. However, a survey of recent efforts suggests that nanoparticles, while they offer important developmental directions, do not automatically, and, naively applied, will not lead to immediate simplistic solutions, based on size alone. Certainly nanoparticles are exceptional in that, due to their
Read full abstract